Skip to main content
. 2020 Dec 22;14(2):100987. doi: 10.1016/j.tranon.2020.100987

Fig. 8.

Fig. 8

MiR-506-3p, EZH2 and β-catenin expression in 92 ovarian cancer patients.

(A) MiR-506–3p expression in ovarian tumors from 92 patients was assessed by miRNA in situ hybridization. (B–D) Samples of ovarian tumors from 92 patients were subjected to IHC staining for EZH2 and β-catenin; Expression of EZH2 and β-catenin protein was calculated as IHC staining scores.